148 related articles for article (PubMed ID: 31208050)
1. Detection of the BRAF V600E Mutation in Colorectal Cancer by NIR Spectroscopy in Conjunction with Counter Propagation Artificial Neural Network.
Zhang X; Yang Y; Wang Y; Fan Q
Molecules; 2019 Jun; 24(12):. PubMed ID: 31208050
[TBL] [Abstract][Full Text] [Related]
2. Clinical Validation of Newly Developed Multiplex Kit Using Luminex xMAP Technology for Detecting Simultaneous RAS and BRAF Mutations in Colorectal Cancer: Results of the RASKET-B Study.
Taniguchi H; Okamoto W; Muro K; Akagi K; Hara H; Nishina T; Kajiwara T; Denda T; Hironaka S; Kudo T; Satoh T; Yamanaka T; Abe Y; Fukushima Y; Yoshino T
Neoplasia; 2018 Dec; 20(12):1219-1226. PubMed ID: 30412858
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of high-resolution melting analysis as a diagnostic tool to detect the BRAF V600E mutation in colorectal tumors.
Pichler M; Balic M; Stadelmeyer E; Ausch C; Wild M; Guelly C; Bauernhofer T; Samonigg H; Hoefler G; Dandachi N
J Mol Diagn; 2009 Mar; 11(2):140-7. PubMed ID: 19213871
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical detection of the BRAF V600E mutant protein in colorectal neoplasms.
Vakiani E; Yaeger R; Brooke S; Zhou Y; Klimstra DS; Shia J
Appl Immunohistochem Mol Morphol; 2015 Jul; 23(6):438-43. PubMed ID: 25517872
[TBL] [Abstract][Full Text] [Related]
5. High frequency of BRAF proto-oncogene hot spot mutation V600E in cohort of colorectal cancer patients from Ahvaz City, southwest Iran.
Asl JM; Almasi S; Tabatabaiefar MA
Pak J Biol Sci; 2014 Apr; 17(4):565-9. PubMed ID: 25911848
[TBL] [Abstract][Full Text] [Related]
6. Preliminary Study on the Identification of BRAF
Duan J; Yang Y; Yin L; Zhang X; Tang Y; Zhang S; Gong H; Xiao M; Li M; Li Q; Li X; Yang L; Fan Q; Wang Y
Onco Targets Ther; 2020; 13():13077-13085. PubMed ID: 33376356
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemistry is a feasible method to screen BRAF V600E mutation in colorectal and papillary thyroid carcinoma.
Zhang X; Wang L; Wang J; Zhao H; Wu J; Liu S; Zhang L; Li Y; Xing X
Exp Mol Pathol; 2018 Aug; 105(1):153-159. PubMed ID: 30009773
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of immunohistochemistry for the detection of the BRAF V600E mutation in colorectal carcinoma.
Ioannou M; Papamichali R; Samara M; Paraskeva E; Papacharalambous C; Baxevanidou K; Koukoulis G
J BUON; 2016; 21(3):618-25. PubMed ID: 27569082
[TBL] [Abstract][Full Text] [Related]
9. BRAF V600E Mutant Colorectal Cancer Subtypes Based on Gene Expression.
Barras D; Missiaglia E; Wirapati P; Sieber OM; Jorissen RN; Love C; Molloy PL; Jones IT; McLaughlin S; Gibbs P; Guinney J; Simon IM; Roth AD; Bosman FT; Tejpar S; Delorenzi M
Clin Cancer Res; 2017 Jan; 23(1):104-115. PubMed ID: 27354468
[TBL] [Abstract][Full Text] [Related]
10. Quantitative analysis of wild-type and V600E mutant BRAF proteins in colorectal carcinoma using immunoenrichment and targeted mass spectrometry.
Chen H; Hsiao YC; Chiang SF; Wu CC; Lin YT; Liu H; Zhao H; Chen JS; Chang YS; Yu JS
Anal Chim Acta; 2016 Aug; 933():144-55. PubMed ID: 27497007
[TBL] [Abstract][Full Text] [Related]
11. Development of ultra-short PCR assay to reveal BRAF V600 mutation status in Thai colorectal cancer tissues.
Chat-Uthai N; Vejvisithsakul P; Udommethaporn S; Meesiri P; Danthanawanit C; Wongchai Y; Teerapakpinyo C; Shuangshoti S; Poungvarin N
PLoS One; 2018; 13(6):e0198795. PubMed ID: 29879227
[TBL] [Abstract][Full Text] [Related]
12. High-sensitivity PCR method for detecting BRAF V600E mutations in metastatic colorectal cancer using LNA/DNA chimeras to block wild-type alleles.
Chen D; Huang JF; Xia H; Duan GJ; Chuai ZR; Yang Z; Fu WL; Huang Q
Anal Bioanal Chem; 2014 Apr; 406(9-10):2477-87. PubMed ID: 24500755
[TBL] [Abstract][Full Text] [Related]
13. Co-existence of BRAF V600E Gene Mutation in Tumor and Non-tumoral Surrounding Tissues in Colorectal Cancer.
Öztürk T; Toptaş-Hekimoğlu B; Eronat AP; Saygili N; Dağlar-Aday A; Başsüllü N; Türkmen I; Aydoğan HY; Bülbül G; Göksel S; Öztürk O; Isbir T
In Vivo; 2015; 29(5):577-84. PubMed ID: 26359417
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of BRAF V600E mutation and microsatellite instability in Japanese patients with sporadic colorectal cancer.
Nakaji Y; Oki E; Nakanishi R; Ando K; Sugiyama M; Nakashima Y; Yamashita N; Saeki H; Oda Y; Maehara Y
J Cancer Res Clin Oncol; 2017 Jan; 143(1):151-160. PubMed ID: 27672042
[TBL] [Abstract][Full Text] [Related]
15. Detection of BRAF V600E mutation in colorectal cancer: comparison of automatic sequencing and real-time chemistry methodology.
Benlloch S; Payá A; Alenda C; Bessa X; Andreu M; Jover R; Castells A; Llor X; Aranda FI; Massutí B
J Mol Diagn; 2006 Nov; 8(5):540-3. PubMed ID: 17065421
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemistry with Anti-BRAF V600E (VE1) Mouse Monoclonal Antibody is a Sensitive Method for Detection of the BRAF V600E Mutation in Colon Cancer: Evaluation of 120 Cases with and without KRAS Mutation and Literature Review.
Dvorak K; Higgins A; Palting J; Cohen M; Brunhoeber P
Pathol Oncol Res; 2019 Jan; 25(1):349-359. PubMed ID: 29127628
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemistry using the BRAF V600E mutation-specific monoclonal antibody VE1 is not a useful surrogate for genotyping in colorectal adenocarcinoma.
Adackapara CA; Sholl LM; Barletta JA; Hornick JL
Histopathology; 2013 Aug; 63(2):187-93. PubMed ID: 23763264
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemistry is highly sensitive and specific for the detection of V600E BRAF mutation in melanoma.
Long GV; Wilmott JS; Capper D; Preusser M; Zhang YE; Thompson JF; Kefford RF; von Deimling A; Scolyer RA
Am J Surg Pathol; 2013 Jan; 37(1):61-5. PubMed ID: 23026937
[TBL] [Abstract][Full Text] [Related]
19. BRAF V600E mutation detection by immunohistochemistry in colorectal carcinoma.
Affolter K; Samowitz W; Tripp S; Bronner MP
Genes Chromosomes Cancer; 2013 Aug; 52(8):748-52. PubMed ID: 23650027
[TBL] [Abstract][Full Text] [Related]
20. Clinical Significance of BRAF Non-V600E Mutations in Colorectal Cancer: A Retrospective Study of Two Institutions.
Shimada Y; Tajima Y; Nagahashi M; Ichikawa H; Oyanagi H; Okuda S; Takabe K; Wakai T
J Surg Res; 2018 Dec; 232():72-81. PubMed ID: 30463788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
